Trial intelligence / Profile preview

Phase III randomized double-blind placebo-controlled study of Suhuang Zhike Granules in children with postinfectious cough

CTR20244714Phase 3Completed

Sponsor
Dongfang Yunjia
Start
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Suhuang Zhike Granules in postinfectious cough, sponsored by Dongfang Yunjia. Started Dec 2024; status: completed.

02

Drugs

Suhuang Zhike Granules
03

Conditions

postinfectious cough

Beyond the preview

Go deeper on CTR20244714.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20244714.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call